Scientific article
English

Safety and efficacy of alefacept in elderly patients and other special populations

Published in

Journal of drugs in dermatology, vol. 4, no. 6, p. 718-724

Publication date

2005

Abstract

BACKGROUND: The safety of biologic agents for psoriasis treatment is of particular importance in patient groups at higher risk for adverse events. We assessed the safety and efficacy of alefacept in elderly, obese, and diabetic patients with moderate to severe chronic plaque psoriasis by integrating data from phase 2 and 3 clinical studies and their extensions. OBSERVATIONS: Ninety-nine elderly, 652 obese, and 122 diabetic patients received at least 1 course of alefacept. In each cohort, accidental injury, headache, and pharyngitis were among the most common adverse events; infections were primarily common colds; and malignancies were mostly skin carcinomas. No opportunistic infections were reported. Safety was maintained over repeated courses. The safety profile of alefacept in each cohort was consistent with that of the overall population; however, additional data are needed to confirm our findings in the elderly and diabetic subgroups in the later courses due to the limited sample sizes. In course 1, 24% to 33% of patients achieved 75% or greater improvement in Psoriasis Area and Severity Index (PASI) at any time, with further enhancement of benefit with subsequent courses (eg, course 3, 41% to 58%). CONCLUSIONS: Alefacept was well-tolerated and effective in elderly, obese, and diabetic patients with psoriasis.

Keywords

  • Age Factors
  • Aged
  • Cholelithiasis/epidemiology
  • Chronic Disease
  • Comorbidity
  • Dermatologic Agents/administration & dosage/adverse effects/*therapeutic use
  • Diabetes Mellitus/epidemiology
  • Drug Administration Schedule
  • Humans
  • Injections, Intramuscular
  • Injections, Intravenous
  • Multicenter Studies as Topic
  • Obesity/epidemiology
  • Psoriasis/drug therapy
  • Randomized Controlled Trials as Topic
  • Recombinant Fusion Proteins/administration & dosage/adverse effects/*therapeutic
  • use
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

UNIGE affiliation entities

Not a UNIGE publication

Citation (ISO format)

GOTTLIEB, Alice B., BOEHNCKE, Wolf-Henning, DARIF, Mohamed. Safety and efficacy of alefacept in elderly patients and other special populations. In: Journal of drugs in dermatology, 2005, vol. 4, n° 6, p. 718–724.

Identifiers

Journal ISSN

1545-9616
525views
0downloads

Technical informations

Creation

20/09/2013 16:32:52

First validation

20/09/2013 16:32:52

Update

14/03/2023 20:24:42

Status update

14/03/2023 20:24:42

Last indexation

30/10/2024 10:15:31
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated